Skip to main content
Equibles
KYMR logo

KYMR · Kymera Therapeutics, Inc. · Held by Funds

Track KYMR — free

Use KYMR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KYMR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$127.57 +0.40 (+0.31%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$10.89B
Shares
85.37M
Volume · Nov 13 808.83K Avg daily vol (3M) 828.66K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of KYMR by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 15.14% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.69% 2,298,965
Index ETFs 12.44% 10,623,720
Active ETFs 0.70% 595,030
Active funds 30.97% 26,440,870
Unclassified 0.06% 54,654
All registered funds 46.87% 40,013,239
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding KYMR

389 fund positions
Fund Balance Value % of Fund Open
Fidelity Growth Company Fund 2,241,647 $266,330,080 0.27%
T. Rowe Price New Horizons Fund, Inc. 2,257,207 $258,833,927 1.76%
VANGUARD TOTAL STOCK MARKET INDEX FUND 2,089,249 $239,574,183 0.01%
T. Rowe Price Capital Appreciation Fund 2,046,104 $234,626,746 0.33%
VANGUARD HEALTH CARE FUND 1,796,469 $185,754,895 0.49%
iShares Russell 2000 ETF 1,607,649 $184,349,111 0.22%
VANGUARD SMALL-CAP INDEX FUND 1,509,757 $173,123,835 0.09%
SMALLCAP World Fund Inc 1,352,248 $155,062,278 0.16%
State Street(R) SPDR(R) S&P(R) Biotech ETF 1,272,754 $145,946,701 1.36%
T. Rowe Price Health Sciences Fund, Inc. 924,967 $106,065,966 0.89%
VANGUARD SMALL-CAP GROWTH INDEX FUND 868,915 $99,638,483 0.21%
T. Rowe Price Small-Cap Stock Fund, Inc. 790,093 $90,599,964 0.97%
VANGUARD EXTENDED MARKET INDEX FUND 726,545 $83,312,915 0.09%
T. Rowe Price All-Cap Opportunities Fund 660,942 $75,790,219 0.52%
Fidelity Growth Company K6 Fund 619,100 $73,555,271 0.26%
VANGUARD EXPLORER FUND 693,227 $71,679,672 0.32%
Fidelity Small Cap Index Fund 684,750 $70,803,150 0.21%
Select Biotechnology Portfolio 556,441 $66,110,755 1.05%
Fidelity Series Growth Company Fund 553,500 $65,761,335 0.27%
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund 567,076 $65,026,605 0.66%
iShares Biotechnology ETF 504,074 $57,802,166 0.64%
Eventide Healthcare & Life Sciences Fund 503,000 $57,679,010 3.22%
Select Health Care Portfolio 480,000 $57,028,800 0.84%
iShares Russell 2000 Growth ETF 477,706 $54,778,547 0.36%
T. Rowe Price Mid-Cap Growth Fund, Inc. 467,146 $53,567,632 0.23%
JNL/T. Rowe Price Capital Appreciation Fund 446,936 $51,250,151 0.33%
T. Rowe Price Institutional Small-Cap Stock Fund 427,717 $49,046,308 0.98%
Federated Hermes Kaufmann Fund 455,212 $47,068,921 0.96%
VIP Contrafund Portfolio 396,100 $45,420,787 0.15%
Fidelity Contrafund 380,242 $43,602,350 0.02%
VANGUARD RUSSELL 2000 INDEX FUND 358,856 $42,635,681 0.24%
Fidelity Advisor New Insights Fund 350,900 $40,237,703 0.14%
Fidelity Extended Market Index Fund 308,060 $36,600,609 0.09%
Schwab U.S. Small-Cap ETF 301,459 $35,816,344 0.16%
Putnam Small Cap Growth Fund 307,841 $35,300,127 1.04%
Fidelity Small Cap Growth Fund 330,653 $34,189,520 0.39%
Strategic Advisers Fidelity U.S. Total Stock Fund 287,700 $34,181,637 0.01%
Fidelity Stock Selector Small Cap Fund 314,000 $32,467,600 0.44%
Federated Hermes Kaufmann Small Cap Fund 284,366 $29,403,444 1.03%
AB Small Cap Growth Portfolio 242,969 $27,861,255 0.89%
PGIM Jennison Health Sciences Fund 215,651 $25,621,495 1.71%
VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO 217,017 $24,885,339 0.36%
Fidelity Advisor Biotechnology Fund 231,700 $23,957,780 1.09%
Fidelity Advisor Health Care Fund 228,000 $23,575,200 0.76%
Fidelity Series Small Cap Opportunities Fund 221,000 $22,851,400 0.48%
AB DISCOVERY GROWTH FUND, INC. 197,291 $22,623,359 0.78%
Fidelity Series Opportunistic Insights Fund 195,100 $22,372,117 0.15%
Voya Small Cap Growth Fund 155,630 $18,490,400 0.87%
MFS New Discovery Fund 150,719 $17,906,924 0.84%
Fidelity Balanced Fund 148,900 $17,690,809 0.03%
Showing 1–50 of 389 positions
Key facts CIK 1815442 CUSIP 501575104 13F (30d) 236 filings 211 filers Visit website Investor relations